CSI-UCSF 2018 , United States of America - Home


October 26 – 27, 2018
San Francisco, USA

CSI-UCSF 2018 , United States of America: Catheter Interventions in Congenital, Structural and Valvar Heart Disease - CSI-UCSF 2018 CSI-UCSF 2018 Catheter Interventions in Congenital, Structural and Valvar Heart Disease
CSI-UCSF 2018 , United States of America

CSI-UCSF
October 26 – 27, 2018
San Francisco, USA



Please subscribe to our
csi pfeil
newsletter

Add to my calendar

CSI-UCSF 2018 Topics Program Details Scientific Faculty Registration Abstracts & Cases Key Information Supporters Archive Event Calendar
Fontsize bigger
  CSI-UCSF 2018 , United States of America: Catheter Interventions in Congenital, Structural and Valvar Heart Disease
CSI-UCSF 2018 , United States of America: Catheter Interventions in Congenital, Structural and Valvar Heart Disease

Board of Directors

Horst Sievert, MD

CardioVascular Center Frankfurt CVC
Frankfurt
Germany

Board of Directors: Horst Sievert, MD
More

Horst Sievert, MD

CardioVascular Center Frankfurt CVC
Frankfurt, Germany

Board of Directors: Horst Sievert, MD
Director and Founder of CVC Frankfurt

Specialist in Internal Medicine, Cardiology, Angiology, and Intensive Care

Medical degree from Johannes Gutenberg University Mainz and Johann Wolfgang Goethe University Frankfurt, Germany

Dr. Sievert has been the Principal Investigator of a number of clinical trials and has authored more than 130 manuscripts and 600 abstracts in peer reviewed journals, as well as 70 books and book contributions. He has also delivered more than 600 invited lectures around the world.
 
He has personally performed more than 16,000 PCIs and 6,000 peripheral angioplasties. However, his activity in the cath lab is focused on highly specialized non-coronary interventions for patients with congenital heart disease, carotid disease, or high risk of stroke, among other conditions. Dr Sievert was the first to close the left atrial appendage percutaneously. He has the largest experience worldwide in catheter closure of heart defects in adults and gets referrals from all over the world.

Neil Wilson, MD

School of Medicine, University of Colorado, Childrens Hospital Colorado
Denver
USA

Board of Directors: Neil Wilson, MD

Randy Lee, MD

University of California
San Francisco
USA

Board of Directors: Randy Lee, MD
More

Randy Lee, MD

University of California
San Francisco, USA

Board of Directors: Randy Lee, MD
Education
1984 UCLA School of Medicine 

Residencies
1988 Harbor-UCLA Medical Center, Internal Medicine
 
Fellowships
1991 Stanford University Medical Center, Cardiovascular Diseases 

Dr. Randall J. Lee graduated from UCLA Medical School in 1984 where he also obtained his doctorate in pharmacology. After completing an internal medicine residency at Harbor-UCLA Medical Center in Torrance, Calif., he completed a cardiology fellowship and postdoctoral fellowship in biochemistry and molecular biology at Stanford University, where he earned a Physician Scientist Award and the Upjohn Young Investigator Award in cardiology. Lee subspecialized in cardiac electrophysiology during his second fellowship at UCSF.
His research focuses on cellular and molecular aspects of cardiac arrhythmias and vascular regeneration. He is investigating the cellular and molecular derangements that occur during cardiac arrhythmias and myocardial infarctions. Lee uses genetic engineering techniques to investigate derangements during cardiac arrhythmias and myocardial infarctions and as possible therapeutic tools. Lee also is interested in cardiac development of the conduction system and the means to alter conduction, which then may be applied to diseased states.

Vaikom Mahadevan, MD

University of California
San Francisco
USA

Board of Directors: Vaikom Mahadevan, MD

Invited Faculty

Information will be available soon.



CSI   CSI
Contact Data Privacy Imprint Home CSI 2017 Visit us on Facebook Visit us on Twitter